IGC Pharma, Inc. cotiza a 0.28 USD y tiene una capitalización bursátil de $29M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment…
| Periodo | 2026-05 | 2025-11 | 2025-06 | 2025-02 |
|---|---|---|---|---|
| Real | $-0.02 | $-0.02 | $-0.01 | $-0.02 |
| Estimado | $-0.02 | $-0.02 | $-0.02 | $-0.03 |
| Sorpresa | +0.0% | +0.0% | +50.0% | +33.3% |
| Métrica | IGC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 48.7% | 57.0% | -8.3% |
| Operating Margin | -585.8% | -38.6% | -547.2% |
| Net Margin | -560.4% | -33.6% | -526.8% |
| FCF Margin | -386.1% | -13.9% | -372.2% |
| ROE | -112.5% | -40.4% | -72.1% |
| ROA | -81.4% | -32.0% | -49.4% |
| Current Ratio | 1.28 | 2.84 | -1.56 |
| Debt / Equity | 0.02 | 0.28 | -0.26 |